Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

56.82 -0.87 (-1.51%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
20 21 Next >
Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH is showing decent growth, but is still valued reasonably.
LANTHEUS HOLDINGS INC was identified as an affordable growth stock. NASDAQ:LNTH is showing great growth, but also scores well on profitability. At the same time it seems to be priced reasonably. 
Via Chartmill
Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member
From Lantheus Holdings, Inc.
Via GlobeNewswire
What 4 Analyst Ratings Have To Say About Lantheus Holdings
 
Via Benzinga
Why Lantheus Holdings (LNTH) Stock Is Down 4%
Lantheus shares are trading lower by 5.4% during Monday's session. The company announced a $350 million acquisition. 
Via Benzinga
Earnings Scheduled For February 26, 2025
 
Via Benzinga
Lantheus (LNTH): A 10x Opportunity in Radiopharmaceuticals
Via The Motley Fool
Earnings To Watch: Lantheus (LNTH) Reports Q4 Results Tomorrow
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings tomorrow before market hours. Here’s what you need to know. 
Via StockStory
NASDAQ:LNTH is not too expensive for the growth it is showing.
LANTHEUS HOLDINGS INC was identified as a growth stock that isn't overvalued. NASDAQ:LNTH is excelling in various growth indicators while maintaining a solid financial footing. 
Via Chartmill
Lantheus to Present at Upcoming Investor Conferences
From Lantheus Holdings, Inc.
Via GlobeNewswire
Despite its impressive fundamentals, NASDAQ:LNTH remains undervalued.
Uncover the potential of LANTHEUS HOLDINGS INC, an undervalued stock. NASDAQ:LNTH maintains a strong financial position and offers an appealing valuation. 
Via Chartmill
Exploring the Growth Potential of NASDAQ:LNTH as It Nears a Breakout.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) qualifies as a high growth stock and is consolidating. 
Via Chartmill
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
P/E Ratio Insights for Lantheus Holdings
 
Via Benzinga
NASDAQ:LNTH is probably undervalued for the fundamentals it is displaying.
LANTHEUS HOLDINGS INC has a stellar value proposition. NASDAQ:LNTH not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point. 
Via Chartmill
Why Lantheus Holdings Stock Got Thrashed on Tuesday
Via The Motley Fool
9 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio
Lantheus strengthens its radiopharmaceutical business with Evergreen and Life Molecular acquisitions, adding oncology and Alzheimer's diagnostics. 
Via Benzinga
Why NASDAQ:LNTH Is a Standout High-Growth Stock in a Consolidation Phase.
Based on a technical and fundamental analysis of NASDAQ:LNTH we ask: Is LANTHEUS HOLDINGS INC (NASDAQ:LNTH) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
Here's How Much You Would Have Made Owning Lantheus Holdings Stock In The Last 5 Years
 
Via Benzinga
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader
From Lantheus Holdings, Inc.
Via GlobeNewswire
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company. 
Via Benzinga
Topics Government
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH is showing decent growth, but is still valued reasonably.
Investors should take note ofLANTHEUS HOLDINGS INC (NASDAQ:LNTH), a growth stock that remains attractively priced. 
Via Chartmill
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices
Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
For those who appreciate value investing, NASDAQ:LNTH is a compelling option with its solid fundamentals.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH): good value for what you're paying. 
Via Chartmill
2 Stock Market Predictions for 2025: 2 Stocks Worth Buying No Matter What Happens
Short-term market predictions are fun, but rarely worth investing in. Here are two stocks we think will be winners no matter what happens with the market in 2025. 
Via The Motley Fool
For those who appreciate growth without the sticker shock, NASDAQ:LNTH is worth considering.
While growth is established for LANTHEUS HOLDINGS INC (NASDAQ:LNTH), the stock's valuation remains reasonable. 
Via Chartmill
This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.